A new antiplatelet agent is developed for the prevention of recurrence of stroke. In a large randomized clinical trial w

Business, Finance, Economics, Accounting, Operations Management, Computer Science, Electrical Engineering, Mechanical Engineering, Civil Engineering, Chemical Engineering, Algebra, Precalculus, Statistics and Probabilty, Advanced Math, Physics, Chemistry, Biology, Nursing, Psychology, Certifications, Tests, Prep, and more.
Post Reply
answerhappygod
Site Admin
Posts: 899603
Joined: Mon Aug 02, 2021 8:13 am

A new antiplatelet agent is developed for the prevention of recurrence of stroke. In a large randomized clinical trial w

Post by answerhappygod »

A new antiplatelet agent is developed for the prevention of recurrence of stroke. In a large randomized clinical trial with equal numbers of men and women, the rates of stroke are lower in patients receiving the new agent than in patients receiving the standard treatment

Women Men Overall
Standard Treatment
.12 .24
New Antiplatelet Drug .04
.08
.00


A) 8o/o
B) 12o/u
C) 16%
D) 33%
E) 50%
F) 62%
G) 67%
H) 75%
Join a community of subject matter experts. Register for FREE to view solutions, replies, and use search function. Request answer by replying!
Top

This question has been solved and has 1 reply.

You must be registered to view answers and replies in this topic. Registration is free.


Register Login
 
Post Reply

Return to “Archived Questions & Answers”